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Assessment of Environmental
Contaminant-Induced
Lymphocyte Dysfunction
by Jay B. Silkworth* and Leland D. Looset
Although it has been established that environmental contaminants can alter immune
function, the mechanisms ofaction have yet to be determined. This paper reviews the effects of
hydrocarbon environmental contaminants on lymphocyte function and presents an approach
which may serve to delineate the mechanisms ofaction. The approach is based on the use ofthe
developmental phases ofan immune response and assays which can be used for their functional
assessment. Possible interactions between environmental contaminants and lymphocyte
function and factors which must be considered in the evaluation of immune status are
discussed. In addition, a study on the influence ofthe chronic exposure to two polyhalogenated
hydrocarbons, PCB and HCB, on several parameters of lymphocyte function in mice is
presented.
Introduction
It has been established by several investigators
that environmental contaminants can alter the
immune response (1, 2). Since lymphocyte function
is integral in the development of an immune re-
sponse, it is appropriate to delineate its role in
environmental contaminant-induced immune dys-
function. It is the purpose of this presentation to
explore the possible interactions between the lym-
phocyte and commercially valuable hydrocarbons
and their impurities which have become environ-
mental contaminants (EC) based on an approach
which may provide insight into the mechanisms by
which they cause immune dysfunction. Factors
which should be considered in the assessment of
chemical-induced immunotoxicity will be discussed
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and data from a study on the influence of two
halogenated hydrocarbons, polychlorinated biphe-
nyl (PCB Aroclor 1016) and hexachlorobenzene
(HCB), on cell-mediated immune function will be
presented.
To assess the functional status ofthe lymphocyte
following exposure to EC it is necessary to under-
stand its role in the development of an immune
response. The primary function of the immune
system is the recognition and elimination ofcellular
andnoncellularentitieswhicharenon-self, (bacteria,
viruses, protozoa, etc.), oraltered-self(transformed
cells), whichwouldotherwisecompromisethehealth
of the host. This requires a mechanism which is
capable of specific recognition ofthe antigen at the
molecularlevel and acomplexnetworkoffunctional
immunocompetent cells. It has been well estab-
lished that the B lymphocyte is required for the
development ofanantibodyresponse and thattheT
lymphocyte is required for the development of a
cell-mediated immune response. Although the role
of the macrophage as an accessory cell in the
immune response must be carefully considered in
the interpretation of EC-induced immunotoxicity
105(3), this presentation will concentrate on hydrocar-
bonEC-induced alterationsoflymphocyte function.
Assessment of Environmental
Contaminant-induced
Immune Dysfunction
The development of an immune response de-
pends upon the proper function of three basic
phases: (a) initial recognition of the antigen, (b)
activation, which includes proliferation and differ-
entiation of reactive clones of lymphocytes and (c)
the expression of immunity (Fig. 1). This concept
can be applied to the assessment of EC-induced
lymphocyte toxicity.
Depending on the nature of the foreign sub-
stance, initial recognition ofthe antigen may occur
through a combination of direct and/or indirect
interactions with receptors on the lymphocyte sur-
face membrane. Some antigens, such as lipopoly-
saccharide (LPS), polymerized flagellin (POL), and
polyvinylpyrrolidone (PVP), whichareT-independent
antigens, can interact directly with specific
immunoglobulin receptors on B lymphocytes. Cellu-
lar antigens such as sheep erythrocytes (SRBC) or
serum protein antigens such as bovine serum albu-
min (BSA) orbovine gammaglobulin (BGG)require
interaction with both B and T lymphocytes for the
development ofhumoral immune responses and are
T dependent antigens. Responses tohistocompatib-
ilityantigens, however, areprimarilydependent on
interactions with T lymphocytes.
Since surface membrane components of immu-
nocompetent cells play such an integral role in the
recognition phase, alteration of either the number
of these surface structures or changes in their
physicochemical properties may lead to a modified
immune response perhaps due to alterations in
cell-cell interactions which are necessary for the
second phase of an immune response, activation.
The importance of the integrity of cell surface
structures and theirpossible alterationbyxenobiotics
can be understood.
Lymphocyte activation follows initial recognition
ofantigen and results in proliferation and differen-
tiation of responding clones oflymphocytes. Many
of the events of activation have been investigated
following stimulation with polyclonal mitogens such
as phytohemagglutinin (PHA) and gram negative
bacterial lipopolysaccharide (LPS). Increased turn-
over and synthesis of phospholipids occurs within
the first hour following exposure to PHA (4, 5). An
increased turnover of the fatty acid moiety of
lecithin is also observed within this time interval
(6). Anincreaseinthe levelofcAMPis notedwithin
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FIGURE 1. Developmental phases of an immune response and assays which can be used for their functional
assessment.
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cs12 min ofPHA exposure and is followed by a gradual
decline to below control levels by 6 hr (7). Nuclear
changes include the increased phosphorylation of
nuclear proteins (8). PHA stimulates RNA synthe-
sis within 30 minutes and protein synthesis within 4
hr followed by DNA synthesis within 24 hr which
reaches a peak between 48 and 72 hr (9). Enzymes
which display increased activity following activa-
tion include acid phosphatase, glucose-6-phosphate
dehydrogenase, lactate dehydrogenase, DNA
polymerase and DNAase (10-14). Morphological
and cytochemical changes also occur following acti-
vation and include lymphocyte enlargement and
basophilia. Exposure to alloantigens results in
similar responses.
The expression of humoral immunity is the pro-
duction of specific antibody and it has been well
established that the B lymphocyte-derived plasma
cell is the effector cell. The expression of cell-
mediated immunity is represented by tissue rejec-
tion responses such as allograft rejection or
graft-versus-host activity in which the effector cell
is the cytolytic T lymphocyte (15). Also, lymphokine
production by T lymphocytes plays a major role in
cell-mediated immune responses such as the resis-
tance to Listeria monocytogenes or the develop-
ment of delayed-type hypersensitivity responses
(16, 17).
Available in vivo and in vitro techniques allow
the examination of the developing immune re-
sponse and perhaps clarification ofthe mechanisms
of EC-induced immunotoxicity (Fig. 1).
Specific Antibody Titer in Serum
The inoculation of test animals with certain
antigens results in the development of a humoral
immune response. The concentration of specific
antibody in serum can be used as a measure ofthe
functional status of all three developmental phases
ofthe humoral immune response. Specific antibody
can be detected by several methods of different
sensitivities which include antigen-antibody immu-
noprecipitation,passivehemagglutination/hemolysis,
hemagglutination/hemolysis and enzyme-linked
immunosorbent assays. The antibody response to T
dependent antigens such as proteins, erythrocytes,
bacterial exotoxins and viruses requires coopera-
tion among B lymphocytes, T lymphocytes and
macrophages (18) whereas the antibody response to
the T independent antigen, LPS, requires B lym-
phocytes and macrophages but not T lymphocytes.
Antibody responses to T dependent versus T inde-
pendent antigens have, therefore, been used by
some investigators (1, 19, 20) to determine the role
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of the T lymphocyte and the B lymphocyte in the
mechanisms of immunotoxic compounds.
Plaque-Forming Cells
When spleen cells are removed from mice which
have been immunized against SRBC and incubated
in a semisolid gel containingthe SRBC antigen, the
subsequent addition of excess complement causes
theformationofclearareas(plaques) where antibody-
and complement-mediated erythrocyte lysis has
occurred (21). Single antibody-producing cells are
responsible for each plaque and the number of
plaque-forming cells (direct PFC) is a measure of
the number of spleen cells which are producing
specific IgM antibody at the time ofthe assay. The
addition to the test system of anti-mouse IgG
immunoglobulin measures the numberofcells which
are secreting specific IgG antibody (indirect PFC).
Since the IgG response to SRBC seems to be
dependent on T lymphocyte regulation (15), the
direct versus indirect PFC count is used by some
investigators (22) to detect alterations in the T
helper lymphocyte population.
Mitogen Responsiveness
Polyclonal mitogens such as PHA and LPS are
thought to activate lymphocytes by binding to
glycoprotein receptors on the cell surface (23).
Although these mitogens seem to bind only certain
glycoproteins which may be present on either T
lymphocyte subpopulations, B lymphocytes, or ac-
cessory cells such as macrophages, their effects are
independent of antigen binding specificity since
polyclonal activation by mitogens results in B
lymphocyte differentiation to cells producing
immunoglobulins of many idiotypes (15) or results
in T lymphocyte differentiation into cells which
express non-specific cytotoxicity. The B lympho-
cyte mitogen, LPS, activates the B lymphocyte
non-specifically at sites other than Ig receptors and
the activation is direct (24). The mechanism of T
lymphocyte activation by PHA is controversial.
The measurement of mitogen-induced (3H)-
thymidine incorporation in lymphocytes is an as-
sessment of the activation phase of the immune
response with the advantage ofby-passing specific
antigen initial recognition (15). The interpretation
of such an experimental design must include the
consideration of the role of the macrophage in
mitogen-induced T lymphocyte activation since it
has been suggested that there are macrophage-
dependent and macro-independent PHA-responsive
T lymphocyte subpopulations (25). The use ofthe B
lymphocyte mitogen, LPS, and the T lymphocyte
107mitogen, PHA, may aid in clarifying the nature of
the chemical-induced lesion, if any, by exposing a
tendency to alter lymphocyte activation in general,
or, T or B lymphocyte activation in particular.
Resistance to Listeria monocytogenes
The inoculation of mice with Listeria monocy-
togenes results in an immune response which is
mediated by T lymphocytes and monocytes (26).
Since immunity cannot be transferred by immune
serum and treatment of immune spleen cells with
anti-theta serum abrogates their ability to confer
resistance (15), the resistance to L. monocytogenes
infection, which is measured by mortality rate or
the numberofviable bacteria present inthe spleen,
liver or serum ofinfected animals, is regarded as a
measure of cellular immunity. However, since the
monocyte is the effector cell it is not possible to
implicate either T lymphocyte or monocyte dys-
function in EC-induced impaired resistance using
this study.
Delayed-Type Hypersensitivity
The subcutaneous administration ofantigens such
as PPD, DNFB, and DNCB to pre-sensitized
animals results in delayed-type hypersensitivity
response. This response is characterized by an
erythematous lesion at the site ofantigen injection
and is due, in part, to the infiltration ofmonocytes
in response to lymphokine production by T lympho-
cytes. The severity ofthe response, as determined
by the degree ofswelling or the amount ofleakage
of intravenously administered radiolabelled com-
pounds into the site, is considered to be an in vivo
measure of all three developmental phases of a
cell-mediated immune response.
Allograft Rejection
Allograft rejection results when a graft such as a
skin graft, which carries histoincompatible anti-
gens, is grafted onto an immunocompetent recipi-
ent. A tissue rejection response mediated by T
lymphocytes is initiated and cytolytic T lympho-
cytes, which are capable of destroying the grafted
tissue, develop. Since a normal rejection response
occurs inthe absense ofB lymphocytes, the allograft
rejection response may be considered to be an in
vivo measure ofall three developmental phases ofa
cell-mediated immune response.
Graft-Versus-Host Response
Injection of immunocompetent cells into an im-
munoincompetent animal expressing histoincomp-
108
atible antigens results in a graft-versus-host re-
sponse (GVHR). It has beenfirmly established that
the GVHR is an expression ofcell-mediated immu-
nity (27) and thatthe response is mediated bythe T
cell (15, 28, 29). The GVHR has three prerequi-
sites. First, the recipient must be unable to react
against the donor cell. Experimentally this may be
accomplished by the injection ofimmunocompetent
parental strain cells injected into young F1 hybrids.
Second, the donor and recipient cells must be
histoincompatible. The injection of parental strain
cells into F1 hybrid recipients satisfies this re-
quirement. Third, the donor cells must be immu-
nocompetent. The severity ofthe graft-versus-host
response induced by immunocompetent cells from
control and treated animals can serve as an assess-
ment of the functional status of the recognition,
activation, and expression phases of the immune
response as indicated by the development of a
completed response, i.e., splenomegaly (30) or the
increase in weight ofthe draining lymph node (31),
and reflects the functional ability of the lympho-
cytes which are involved (32).
Mixed Lymphocyte Responsiveness
The mixed lymphocyte response (MLR) is gener-
ally accepted to represent the recognitive and
proliferative phases of the cell-mediated immune
reaction (33-35). It is accepted that differences in
the antigens which are coded for by the I region of
the H-2 locus, Ia antigens, are the predominant
stimuli in the mixed lymphocyte response (MLR)
and GVHR (15) and are present on T and B
lymphocytes and macrophages but are not found on
erythrocytes, brain, liver and kidney tissue or on
fibroblasts (36). In addition to the antigens coded
for by the H-2 locus, the antigens coded for by the
Mls locus, which is outside the H-2 complex, are
important stimuli in the MLR (37) and these
antigens are present only on B cells (38).
There is extensive evidence which indicates that
the cells which respond to Ia differences are T
lymphocytes (39-41) and it is known that the
receptor is antigen specific, is on or near the cell
surface and can be readily synthesized (42, 43). In
addition, the receptor may be controlled by the Ir
gene (44) which may also regulate T cell, B cell and
macrophage interaction (15). Therefore, the pre-
sentation of alloantigen of irradiated stimulator
cells to responder cells in vitro results in a
proliferative response by the responder cells which
can be quantitated by (3H)-thymidine incorporation
and can be used as an evaluation ofthe recognition
and proliferation phases of EC-exposed responder
cells.
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T lymphocyte-mediated cytotoxicity is recognized
as the final effector phase of cell-mediated immu-
nity (15). Although Ia differences are sufficient for
the development of a MLR, H-2K or H-2D region
differences are also required for optimal in vitro
cell-mediated lymphocytotoxicity (CML) (45). An-
tigens coded forbythe H-2D and H-2Kregion have
been found on all the cells which have been tested
(15). Direct cytotoxicity is primarily mediated by
the T lymphocyte (46, 47) and evidence indicates
that one population of T lymphocytes must recog-
nizetheIadifferencesandinteractwiththecytotoxic
T lymphocyte (CTL), which directs its activity
against H-2K and H-2D differences. In addition,
separate populations of CTLs are directed against
either H-2D or H-2K antigens (48).
Target cell lysis begins with brief contact of
CTLs with target cells and results in target cell
death within 3-24 hr(49). Since thisresponse canbe
inhibited by either a millipore barrier between the
target cells and the lymphocytes, antisera against
the target cell or trypsinization of the cytotoxic
lymphocyte, T cell recognition and contact with the
target cell surface appears to be necessary for
target cell destruction (50, 51).
Cell-mediated lymphocytotoxicity (CML) can be
assayed by several in vitro techniques including
short-term 51chromium release from 51chromium-
labeled target cells and is an assessment of the
effector phase of the expression of cell-mediated
immunity (15, 52). Although the recognition and
activation phases of the response to alloantigens
may be intact as indicated by comparable values in
MLR (3H)-thymidine incorporation between cells
from control and chemical-treated animals, the
cytotoxic mechanisms may, nevertheless, be func-
tionally impaired.
Lymphokine Production
Lymphokines are products of activated T lym-
phocytes and play an important role in local im-
mune responses such as the delayed-type hyper-
sensitivity response. The activity of lymphokines
such as migration inhibitory factor (MIF) or macro-
phage activatingfactor(MAF) producedbyisolated
lymphocytes from EC-exposed animals which have
been activated in vitro by stimulated macrophages
isolated from normal animals can be measured in
vitro with macrophages from normal animals. The
activity oflymphokines, therefore, can be used as a
measure ofT lymphocyte function which may serve
to dissect EC-inducedlymphocyte impairmentfrom
monocyte impairment incell-mediated immune dys-
function and deserves more attention.
Influence of Environmental
Contaminantson Immune Function
Possible mechanisms by which EC may directly
or indirectly influence the development of an im-
mune response are shown in Figure 2. Molecular
ENVIRONMENTAL CONTAMINANT
INDIRECT INTERACTION
WITH LYMPHOCYTE
1) Nutritional deficiences
2) Endocrine imbalance
-> MODIFIED IMMUNE RESPONSE
FIGURE 2. Influence of environmental contaminants on immune function.
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WITH LYMPHOCYTE
1) Molecular interference with cell
surface receptors or with humoral
factors required for antigen
recognition and cell cooperation
2) Metabolic alterations of enzyme
activities, DNA/RNA synthesis, etc.
3) Direct cytotoxicity causing cell
death
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109interference with the production or function ofcell
surface receptors could result in a partial or com-
plete loss of lymphocyte function or in changes in
receptor specificity or affinity for antigen in addi-
tion to impairment of the cooperation among lym-
phocytes and accessory cells. Dandliker et al. (53)
have demonstrated, however, that although post-
immunization administration of pesticides, such as
Dinoseband Parathion, reducedtheserumovalbumin
antibody concentrations in hamsters, there were no
alterations in antibody binding affinity. TCDD (2,
3, 7, 8-tetrachlorodibenzo-p-dioxin)-induced alter-
ation of lymphocyte cell membranes has been
suggested by Faith (54) as a possible mechanism of
toxicity. Metabolic interference with lymphocyte
enzyme activities or DNA/RNA synthesis in lym-
phocytes in mitosis would result in inadequate
numbers of reactive cells. Compounds such as
azothioprine, methotrexate, and cyclophosphamide
act in this way to cause therapeutic immunosup-
pression. EC may also be directly cytotoxic to stem
cells in bone marrow or thymus and could cause
selective depletion of chemical-sensitive clones of
precursor or mature lymphocytes such as suppres-
sor or effector T lymphocytes, B lymphocytes, or
memory cells.
EC may also indirectly influence immune
responsiveness by altering the nutritional status of
the host (55-57). Chemical-induced alteration of
endocrine function which would result in elevated
glucocorticoid levels and steroid imbalance has also
been suggested as a cause of immune dysfunction,
however, studies with polybrominated biphenyl
(PBB) and TCDD, which cause depletion of the
hydrocortisone-sensitive cortical thymocytes, have
not supported this hypothesis (22, 58, 59).
An EC may also directly interact with an antigen
to alter its recognition by the immune system or
alter sensitivity to immune attack.
Any of the above alterations of lymphocyte
function may result in a modified immune response
due to: (1) an over- orunder-regulated response, (2)
altered antigen recognition, (3) the inability of
reactiveclonestoexpandinnumber, (4)aninsufficient
number of reactive precursor cells, or (5) altered
affinity or specificity for the antigen.
Lymphoid Processing of
Environmental Contaminants
The influence of the lymphocyte on the disposi-
tion ofthe environmental contaminant must also be
considered (Fig. 3). The compound, for example,
ENVIRONMENTAL CONTAMINANT
SPECIFIC HANDLING
1) antigen
2) hapten
RESULT
1) antibody-compound
immune complex formation
2) immune clearance of
compound
3) auto-immune disease
FIGURE 3. Lymphoid processing of environmental contaminants.
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NON-SPECIFIC HANDLING
1) absorption of compound through
gastrointestinal lymphatics
2) concentration into
lymphoid tissue
3) biotransformation of
compound ?
RESULT
1) altered absorption,
metabolism, disposition,
and excretion of compound
110may be immunogenic. This would result in an
immune response directed against the compound.
Antibodies to DDT, malathion and dieldrin have
been demonstrated (60, 61). Alternatively, the
compound may complex with protein (62) and act as
a hapten (63-65) and result in antibody directed
against the hapten-protein conjugate which may
lead to the formation of immune complexes. This
mechanism for the pathogenesis of vinyl chloride
disease has been suggested by Ward et al. (66).
The lymphocyte may also be involved in the
nonspecific handling of the EC. Since it has been
demonstrated that some compounds are absorbed
by the lacteals and carried through the thoracic
duct before they enter the general circulation (67),
it is possible that the T lymphocyte, which is the
predominant lymphocyte in the thoracic duct, pas-
sively adsorbs the compound and transports it to
lymphoid tissue where it is released down a concen-
tration gradient. This hypothesis would partially
explain the ability oflymphoid tissue to concentrate
xenobiotics to concentrations above serum levels
(Results section).
Immunotoxicity of Hydrocarbon
Environmental Contaminants
Table 1 lists the results ofseveral studies on the
effects of environmental contaminants on different
functional parameters of both humoral and cell-
mediated immune responses. Although these stud-
ies demonstrate that exposure to environmental
contaminants results in immune dysfunction, com-
parison ofthese studies for the purpose ofdefining
a mechanism of immunotoxicity is difficult since
only one parameter of the immune response is
assessed in each study. Furthermore, there is great
variability, from one study to another, in the age
and species ofthe test animal, in the concentration
and formulation of the compound and in the route
and duration of exposure to the compound.
Several recent studies, however, have attempted
todeterminepossiblemechanisms ofimmunotoxicity
by testing more than one immune parameter in
animals on the same experimental protocol (Table
2). Forexample, Vos et al. (19) fed 0, 500, 1000, and
2000 mg HCB/kg to weanling rats for 3 weeks and
Table 1. Compounds tested for immunotoxicity using a single parameter of immune function.
Test Ref-
Compound animal Immune parameter tested Antigen Effect erences
Humoral immunity
DDT Chicken Serum antibody BSA (bovine serum albumin) Decrease (68)
DDT Chicken " BSA No effect (69)
DDT Chicken " Salmonella pullorum No effect (69)
DDT Human " Diptheria No effect (70)
DDT Rabbit " Salmonella typhi Decrease (71)
DDT Rat " Diptheria Decrease (72)
DDT Rat
ft Ovalbumin Decrease (73)
HBB Guinea pig " Tetanus toxoid Decrease (74)
Mirex Chicken " BSA No effect (68)
PCB Aroclor 1221 Rabbit " PRV (Pseudorabies virus) Decrease (75)
PCB Aroclor 1242 Rabbit " PRV Decrease (75)
PCB Aroclor 1254 Rabbit " PRV Decrease (75)
Ametryne Mouse Number of plaque-forming cells SRBC (sheep erythrocytes) Decrease (76)
Carbaryl Mouse " " SRBC Decrease (76)
Chlordimeform Mouse " SRBC Decrease (76)
DDT Chicken " SRBC No effect (68)
DDT Mouse " SRBC Decrease (76)
DES Mouse " SRBC No effect (77)
DES Mouse LPS (lipopolysaccharide) Decrease (77)
HCB Mouse SRBC Decrease (80)
Mirex Chicken SRBC Decrease (68)
Orthophenylphenol Mouse DNP-Ficoll Decrease (78)
Orthophenylphenol Mouse SRBC Decrease (78)
Parathion Mouse SRBC Decrease (76)
PBB Mouse SRBC Decrease (79)
PCB Aroclor 1242 Mouse SRBC Decrease (80)
Cell-mediated immunity
TCDD Mouse Allograft rejection time Transplantation antigens Increase (81)
TCDD Mouse Graft-vs-host response Transplantation antigens Decrease (82)
TCDD Rat Delayed-type hypersensitivity Tuberculin No effect (82)
TCDD Mouse T-lymphocyte mitogen PHA (phytohemagglutinin) Decrease (83)
Vinyl chloride Mouse T-lymphocyte mitogen PHA Increase (84)
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112demonstrated that although the titer of serum
antibody to tetanus toxoid, a T dependent antigen,
was significantly increased, the titer of serum
antibody to LPS, a T-independent antigen, was not
significantly different from control values. Also,
HCB administration had no significant effect on
cell-mediated immune functions such as the resis-
tance to Listeria monocytogenes infection, skin
transplant rejection times or delayed-type hyper-
sensitivity reactions. Therefore, the author con-
cluded that although postnatal exposure to HCB
does not significantly influence cell-mediated im-
munity, it has a stimulative influence on humoral
immunity and suggested that T helper cell function
may be enhanced by HCB. However, since spleen
cell responsiveness to a B mitogen was also
significantly increased, the sensitivity of the B
lymphocyte to immunologic alteration following
HCB exposure cannot be ignored and it is possible
that the B lymphocyte may be more responsive to
both humoral factors, produced during an immune
response by T helper cells, and mitogens. This
suggests, perhaps, an HCB-induced increase in
receptor affinity or avidity for regulating factors.
In order to test the sensitivity ofthe developing
immune system in young animals to the effects of
HCB, Vos et al. (87) fed pregnant rats a diet
containing 50 or 150 mg HCB/kg from days 1-3 of
pregnancy through weaning and continued the
exposure ofthe pups tothe same dietsuntil 5weeks
of age when several parameters of humoral and
cell-mediated immunity were assessed. Cellular
immune resistance to Listeria monocytogenes was
significantly decreased although allograft rejection
time and PHA and Con A mitogen responsiveness
were unaltered. Serum antibody titers to the T
dependent antigens, tetanus toxoid and Trichinella
spiralis, however, were significantly increased and
the author concluded, based also on a previous
study (19), that HCB suppresses cellular immunity
and enhances humoral immunity and that the
developing immune system is more vulnerable to
chemical insult than the established immune sys-
tem of the adult. Faith and Luster (54) demon-
strated with rats that either pre- or postnatal
short-term exposure to TCDD during the develop-
mental period of the immune system caused a
decreased T mitogen responsiveness and delayed-
typehypersensitivityresponsivenesswhichrecovered
by 270 days ofage and, therefore, showed that the
effects are reversible. There was no alteration of
the antibody response to BGG and it was suggested
that T helper function was not altered by TCDD
exposure but that TCDD effects a distinct
subpopulation of T cells which do not have helper
activity but are functional in other cell-mediated
immune responses (58, 93).
A study by Luster et al. (90) indicated that
although short-term exposure to 0.03-30mgPBB/kg
could reduce spleen cell responsiveness to the B
lymphocyte mitogen, LPS, in mice and could re-
duce the spleen cell responsiveness to the T cell
mitogens, PHA and Con A, in both mice and rats,
the antibodyresponseto SRBC wasnotsignificantly
impaired in either mice orrats. In contrast, howev-
er, Fraker (22) reported that short-term exposure
ofmice to 10, 100, and 1000 ppm PBB in their diet
reduced both the direct and indirect plaque anti-
body response to SRBC but that the delayed-type
hypersensitivity response was unimpaired and
suggested that PBB affected B cells and helper T
cells. The influence ofPBB onthe immune response
remains unclear.
Since the involvement of the immune system in
the expression ofenvironmentalchemicaltoxicityis
evident following short-term exposure, it is appro-
priate to determine the sensitivity of lymphocyte
function to modification following chronic exposure
to xenobiotics, to delineate the mechanism offunc-
tional alteration of the lymphocyte and to simul-
taneously develop a test system for the assessment
of the potential toxicity of new chemicals. Most
studies, however, which have evaluated the influence
of EC on lymphocyte function have followed an
experimental design in which the test compound is
administered to the test animal either daily or
weekly for a period ofup to several weeks at which
time different parameters of the immune system
are challenged with the appropriate antigens and
the response is measured on one day only. This
approach does not take into account several charac-
teristics ofeitherthe immune response or exposure
patterns to EC.
The immune response is characterized by an
antigen specific temporal response which depends
on the ability of the lymphoid system to react
quickly and support rapid amplification of the
number of reactive cells. Protocols for the assess-
ment of EC alteration of immune responsiveness
should, therefore, examine alterations in the
specificity of the response and its amplitude and
temporal distribution. In addition, since exposure
to EC is characterized by chronic exposure to
compounds at low concentrations, during which
immune responsiveness could vary considerably
due to: (a) the continuous replenishment of new
reactive cells to the lymphocyte pool, (b) changes in
the pattern ofbiohandling ofthe compound and its
metabolites, and (c) changes in the local environ-
ment ofthe lymphocyte in lymphoid tissue, such as
June 1981 113age changes or changes in the concentration ofthe
compound, the effects oflong-term exposure should
be examined at appropriate intervals.
Therefore a study was designed to assess the
influence of the chronic exposure of two poly-
chlorinated aromatics of environmental interest,
PCB (Aroclor 1016) and HCB, on the three devel-
opmental phases of the immune response in mice.
Lymphocyte function was assessed at intervals
during the chronic exposure period and only one
form of antigen was used (the transplantation
antigens) in addition to the lymphocyte mitogens
LPS and PHA. When possible, the lymphocyte
response was evaluated during the entire period of
the primary response. In addition, the concentra-
tion of each compound in spleen, thymus and liver
tissues, spleen cells and serum was determined at
each exposure interval for comparison of lympho-
cyte function with the compound concentration.
Since much is known about the major histo-
compatibility complex (MHC) of the mouse (H-2)
and many of the antigens, receptors and mecha-
nisms of cell-cell interactions have been well-
documented (15, 27, 33), the histocompatibility
complex was employed as the experimental antigen
and antigen-responsive system.
Many immune responses are controlled by the
H-2 complex (95), for example, the production of
transplantation antigens, cell-mediated lympholysis
oftarget antigens, the mixed lymphocyte reaction,
the graft-versus-host response, the productionofIa
antigens and lymphocyte interactions. Immunotoxic
compounds could interfere with the production,
expression or function of the H-2 controlled anti-
gens and, thereby, result in a decrease in antigen
recognition during the initial encounter or during
the final effector stage as well as a modification of
the normal metabolic and interactive processes of
an immune response. Also, since the H-2 complex
controls immune responses to several antigens (96),
it is possible that the H-2 complex may be involved
in the response to toxic compounds.
Materials and Methods
Animals
Male C57BL/6Tex mice with a histocompatibility
gene complex denoted as H-2b, male B6D2F1
(H-2b,d) mice (BDF1), pregnant C57BL/6Tex mice
which had been mated with D6B2A/2 (H-2d) mice
(DBA) and male DBAmice were supplied by Timco
Texas. Male AKR mice (H-2k) were supplied by
Jackson Laboratories, Bar Harbor, Maine. Mice
were purchased at an initial weight of 18-20g.
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All mice were housed in the Animal Facility at
Albany Medical College. Control animals were fed
Wayne mash. Experimental animals were fed adiet
containing either 167 ppm Aroclor 1016 (PCB) or
167 ppmhexachlorobenzene (HCB) inWayne mash.
Food and water were provided ad libitum. Body
and organ weights were determined foreach exper-
imental period and the relative organ weights were
calculated. An analysis of variance and the Stu-
dent's t-test were used to determine statistical
significance of differences between control groups
and experimental groups at p
- 0.05.
Chemicals
The test chemicals used were the polychlorinated
biphenyl mixture Aroclor 1016 (Monsanto) and
hexachlorobenzene (C6CI6) (HCB) (Eastman practi-
cal grade) which was purified by passage through
activated charcoal and then recrystallized two times
from boiling benzene. Both compounds were dis-
solved in acetone for incorporation into Wayne
mash and mixed for at least 2 hr. Liquid-gas
chromatographic analyses were conducted to as-
sure the proper concentration ofthe test chemicals
in the diets.
Tumor Cells
The methylcholanthrene-induced DBA/2 lympho-
ma, P388, benzopyrene-induced C57BL/6 lympho-
ma, EL-4, and the spontaneous DBA/2-derived
mastocytoma, P815, were maintained in ascites
form byweeklyintraperitoneal (IP) inoculation and
serial passage.
Spleen Cell Isolation Procedure
Mice were killed by cervical dislocation and
weighed. A midline ventral incision into the perito-
neal and thoracic cavities exposed the major vis-
ceral organs for gross examination in situ and
allowed a blood sample to be taken from the
abdominal vein. Spleens were removed aseptically
and weighed in a sterile tissue culture dish (Falcon
3001, 35 x 10 mm, Oxnard, Calif.). The thymus,
lung and liver were then removed and weighed.
Approximately 10-60 mg samples ofeach tissue, in
addition to 100-200 ,ul of the final spleen cell
suspension (0.5-1 x 10' cells) and 100-200 ,ulserum,
were frozen in glass vials for later liquid-gas
chromatographic analysis forPCB orHCB content.
Only those groups of mice used in mixed lympho-
cyte cultures were used for body and organ weight
data(n = 5-6pergroup). Thespleenwasthenteased
across sterile #60 mesh stainless steel into cold
Environmental Health PerspectivesHBSS (Hank's balanced salt solution) and trans-
ferred into polypropylene tubes (Falcon 2059, 17 x
100 mm, Oxnard, Calif.). Cells which remained in
suspension after a 5-min settling period were used,
thereby discarding unwanted debris and cell ag-
gregates. Cell yield and viability were assessed
immediately using trypan blue (0.4% Trypan Blue
in saline (GIBCO)) mixed 1:10 with the cell suspen-
sion and appropriately diluted with 3% acetic acid
and counted usingahemacytometer. The cells were
then washed three times in cold HBSS and spun at
180gand suspended toaconcentration of5 x 106/ml
with RPMI 1640 media (GIBCO) and 10% heat-
inactivated (57°C, 30 min) fetal bovine serum
(FBS) (GIBCO). Cell suspensions were kept on ice
and recountedjust before they were dispensed into
cultures to assure proper concentrations. In addi-
tion, a portion of the isolated spleen cells was
diluted to a concentration of5 x 105/ml with media
and 200 RI of this suspension was pelleted onto a
glass slide using a Cytospin (1000 rpm x 5 min)
(Shandon Elliott, Camberley, Surrey, England).
The cells were stained with Wright's stain and
counted by differential cell count.
Graft-Versus-Host Response (GVHR)
A GVHR was induced in neonatal (< 24 hr)
BDF1 mice by the IP injection of 1 x 107 spleen
cells isolated from either control or chemical-
treated C57BL/6 mice following 3, 6, 13, or 37
weeks of dietary administration of the test chemi-
cal. Spleencellsfrom4-10donorC57BL/6mice from
each diet group were used for the GVHR assay.
The degree of splenomegaly was determined for
each of the 4-18 neonatal recipient BDF1 mice
which were used for each diet group after each diet
treatment interval. The inoculum was administered
in a volume of 0.5 ml RPMI 1640. Injection of
spleen cells isolated from control BDF1 mice
(isogeneic) served as a negative control for the
GVHR. The split-litter procedure (97) was used to
obviate experimental error due to variation be-
tween litters and to allow comparison of test
chemicals within litters. Spleen and body weights
of the neonates were determined on the ninth day
ofmaternalrearingfollowinginoculationwithspleen
cells. Results are expressed as the spleen index
which was calculated bydividingtherelative spleen
weight of neonates inoculated with cells from con-
trol or chemical treated donors by the mean rela-
tive spleen weight of non-injected littermates. A
spleen index ofgreater than 1.3 was considered to
be a positive GVHR (98). Analysis of variance and
the Student's t-test were used to deternine statis-
ticalsignificance betweenpositiveGVHRresponses.
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Mixed Lymphocyte Response (MLR)
One-way MLR assays were conducted using a
modification ofthe procedure describedby Richand
Rich (99). Responder splenocytes from either con-
trol or chemical-treated adult male C57BL/6 mice
(4-6 mice per group) were either cultured alone, for
the determination of the rate of background DNA
synthesis, or co-cultured with equal numbers (5 x
105 cells) of allogeneic stimulator splenocytes from
control DBA mice. Cultures were contained in a
final volume of 0.2 ml RPMI 1640 (GIBCO)
supplemented with a 2 mM L-glutamine (GIBCO),
10% FBS and 50-100 units penicillin (GIBCO) and
50-100 ,g streptomycin (GIBCO) per ml (P-S) in
96-well flat bottom microtiter plates (Falcon 3040,
Micro-test II with lids) in a humidified atmosphere
of5% CO2at 370C (National Appliance, model 3341,
Portland, Ore.) for 1-6 days. Viability and cell
number of microcultures were determined daily.
Splenocytes used as the stimulator cells were
irradiated (2000 rads, GammatorCs-137 Irradiator,
Model M-38-1, Isomedix Inc., Parsippany, N.J.),
washed three times in cold HBSS, and suspended
to the proper concentration in media.
DNA synthesis was assayed by the addition to
each culture of1.0 ,uCitritiated thymidine (NET-027,
methyl-(3H)-thymidine, specificactivity6.7Ci/mmole,
New England Nuclear Corp., Boston, Mass.) for
the last 18 hr of culture. Cells were harvested by
aspiration onto glass fiber filter strips by using an
automated sample harvester (Skatron, Flow Labo-
ratories, Rockville, Md.). The filter discs were
dried, and the radioactivity of triplicate cultures
was measured in 3 ml universal LSC cocktail
(Aquasol-2, New England Nuclear Corp.) by using
anautomaticliquidscintillationspectrometer(Packard
Tri Carb Model3390, Downers Grove, Ill.) (counting
period, 2-5 min, (3H) channel, 50% gain, 50-1000
window). Data are presented as the arithmetic
mean + standard error of the counts per minute
(cpm) oftriplicate cultures. An analysis ofvariance
and the Student's t-test were performed to deter-
mine the statistical significance of the differences
between the means of control groups and experi-
mental groups at p
- 0.05.
Mitogen-Induced Blast Transformation
Mitogen responsiveness assays were conducted
using the same method as employed in mixed-
lymphocyte cultures; however, either 40 ,ug/ml
phytohemagglutinin(PHA-M, B grade, Calbiochem,
LaJolla, Calif.) or 10pug/mlgramnegative bacterial
lipopolysaccharide (LPS, Salmonella typhosa,
Westphal, Difco, Detroit, Mich.) were added to the
115cultures as a stimulus in place of allogenic cells
when the cultures were first established.
Cell-Mediated Lymphocytotoxicity
Sensitizedlymphocytes fromC57BL/6miceimmu-
nized with the DBA/2 tumor, P815, were tested for
their ability to recognize and kill cells which ex-
press alloantigen (H-2d). The DBA/2 tumor, P388,
was used as target cells to obviate anti-tumor
antigen activity directed against P815 tumor anti-
gen. The PHA-induced AKR blast splenocyte (H-2k)
was used as atarget cell to detect chemical-induced
nonspecific killing and the C57BL/6 tumor, EL-4,
(H-2b) was used to detect chemical-induced alter-
ation of recognition of self.
Immunizations. Control and chemical-treated
male C57BL/6 mice (4-6 mice per group) used in
cytotoxicity assays were inoculated IP with 3 x 107
live P815 mastocytoma cells in0.5ml HBSS 10 days
prior to spleen cell isolation. Tumor cells used for
the immunization were harvested from DBA mice
inoculated ip 7 days earlier with 1 x 106 P815
mastocytoma cells.
Labeling ofTargetCells. P388 and EL4 tumor
cells were obtained by peritoneal lavage with a 22
gauge needle by using 5 ml HBSS from isogeneic
earlier. PHA-induced blast lymphocytes were pre-
pared by culturing spleen cells from adult male
AKR mice for 2 days (1 x 106/ml) with 40 ,tg
PHA-M/ml. Prior to labeling, target cells were
washed two times in HBSS and suspended to 2-20
x 106/ml in media without serum. The cells were
labeled by incubating 0.5 ml cell suspension with
100-200 ,uCi 51Cr (0.1-0.2 ml, NEZ-030S, sodium
chromate in saline solution, specific activity 200-500
Ci/g, New England Nuclear Corp.) in a 50 ml
conicaltest tube on analiquot shakerin ahumidified
atmosphere of 5% CO2 at 37°C for 45-60 min. The
labeled cells were then washed five times with 20
ml HBSS supplemented with 10% FBS, counted
and suspended to a concentration of 2 x 105/ml.
Cytotoxicity Assay. Spleen cells from control
and chemical-treated nonimmunized C57BL/6 mice
immunized with P815 mastocytoma cells 10 days
earlier were suspended in media RPMI 1640
supplemented with 2 mM-glutamine and 10% FBS
and dispensed, in duplicate, into 96-well, flat bot-
tommicrotitertrays in 100 ,il volumes. Spleen cells
were not pooled. Chromium-labeled target cells
(P388, AKR blast, and EL-4) were then added in
100 ,lI volumes of the same media to the appropri-
ate wells. The effector cell:target cell ratio was
100:1 in all cultures, i.e., 2 x 10 effector cells:2 x
104 target cells per well. In addition, C57BL/6
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effector cells were mixed with P388 target cells at
ratios of 30:1 and 10:1 for later construction of
titration curves for the determination ofthe ED50
for specific lysis (100). Spontaneous release of the
label was determined by incubating target cells in
media only. The microtiter plates were spun at 25g
for 2 min to increase cell-cell contact and minimize
reaction time and then incubated withoutrockingin
a humidified atmosphere of 5% CO2 at 37°C. To
examine the kinetics of the cytotoxic response the
specific lysis was determined after 3 and 5 hr of
incubation, at which times the plates were spun at
500 g for 10 min at 7°C. A 100 ,u portion of the
supernatant of each well was transferred into a
polystyrene gamma counting tube (15.6 x 125 mm,
Amershan, Arlington Heights, Ill.) and counted for
1 min in an automatic gamma counting system
(Searle, Model 1185 Series, Searle Analytical Inc.,
Waltham, Mass.) with the window centered at 3221
KeV and with a width of 100 KeV.
The experimental release (ER) of label was
determined by calculating the mean counts per min
(cpm) of the supernatant samples of duplicate
cultures, less background counts, of each culture
containing effector cells and labeled target cells and
multiplying by 2 to account for the volume of
supernatant actually counted. The spontaneous
release (SR) for each target cell type was deter-
mined by calculatingthemean cpmofquadruplicate
cultures of labeled target cells, less background,
and multiplying by 2 to account for the fraction of
the total volume of supernatant actually counted.
The maximal release (MR) oflabel was determined
by mixing 100 RI labeled target cells with 300 RI
distilled water in polypropylene tubes (Falcon,
2058) which were passed through four freeze-thaw
cycles. The mean cpm, less background counts, was
then calculated and multiplied by 4 to account for
the volume actually counted. Thetotalincorporated
label was determined by calculating the mean cpm,
less background counts, of eight 100 Rl samples of
labeled target cells. The percent specific 51Cr re-
lease was then calculated as follows: % specific 51Cr
release = (ER - SR)/(MR - SR) x 100. Data are
presented as the arithmetic mean + standard error
of the percent specific 51Cr release calculated for
individual mice (n = 3-6) ofthe control and experi-
mental groups. An analysis of variance and the
Student's t-test were used to determine statistical
significance ofthe difference between the means of
controlgroups and experimental groups atp
- 0.05.
Organochlorine Residue Analysis
Liquid-gas chromatographic analysis of Aroclor
1016 and HCB was conducted using a modification
Environmental Health Perspectivesofthe procedure described by Loose et al. (80) and
Holden and Marsden (101).
Results
Graft-Versus-Host Response
The inoculation of neonatal BDF1 mice with 107
spleen cells from C57BL/6 mice which were fed
either a control diet or a diet containing 167 ppm
PCB for 3, 6, 13, or 37 weeks or a diet containing
167 ppm HCB for 3, 6, or 13 weeks resulted in a
positive graft-versus-host response in all groups.
No significant effect of chemical exposure of the
donors on the GVH response was demonstrated
(Table 3). However, exposure to HCB for 37 weeks
resulted in a significant reduction of 20% in the
graft-versus-host activity of HCB-treated cells.
Spleen cells from normal BDF1 mice did not
produce a GVHR in neonatal BDF1 mice.
Spleen Cell in Vitro Background DNA
Synthesis, Viability, and
Differential Counts
Spleen cells isolated from mice which were fed
PCB for 3, 6, 13, 24, and 40 weeks and cultured in
media for 1-6 days did not show any alterations in
DNA synthesis during the culture periods as com-
pared to control cultures (Fig. 4). In addition, the
number of viable cells per culture for each day of
culture, which was determined only in the 3 and 40
week groups, was comparable to control values at
both diet duration intervals tested (data not
presented). These results indicate that PCB did not
alter culture viability. Also, there were no shifts
from control values in the population densities of
small or large lymphocytes, polymorphonuclear
leukocytes or macrophages in either the 3 or 40
week groups (data not presented).
Spleen cells from mice which were fed 167 ppm
HCB for 3 weeks (Fig. 4) and cultured in media for
1-6 days, demonstrated no alterations in DNA
synthesis as compared to control values, for the
culture period. However, spleen cells from mice
which were fed HCB for 6, 13, 24, and 40 weeks
demonstrated a pattern ofincreased DNA synthe-
sis during the first day of culture. It was first
observed in the 6-week group (205% increase). In
the 13-week group, DNA synthesis was elevated
279% during the first day of culture and fell to
below the control value by the third day. The
increase in DNA synthesis during the first day of
culture in the 24 week group was significantly
above (1431%) control values and remained above
control values through the second day ofculture. In
the 40 week group, DNAsynthesis was 628% above
the control value on the first day ofculture but was
comparable to the control values thereafter. There
were no differences from control values in the
number of viable cells throughout the culture
period in the 3- or 40-week groups (data not
presented). In addition, in the 3- and 40-week
group there were no alterations from control values
in the cell population densities of small or large
lymphocytes, polymorphonuclear leukocytes, and
macrophages (data not presented).
Mixed Lymphocyte Response (MLR)
Spleen cells isolated from C57BL/6 mice which
were fed either a control diet or a diet containing
167 ppm PCB 1016 or HCB for 3, 6, 13, 24, or 40
weeks responded with a transient increase in DNA
synthesis when stimulated in a one-way mixed
lymphocyteculture withequalnumbersofirradiated
spleen cells from DBA mice (Fig. 4). Peak DNA
synthesis by C57BL/6 spleen cells from control,
PCB- and HCB-treated groups stimulated by DBA
cells occurred on the sixth day of culture in the
3-week group, on the fifth day ofculture for spleen
cells from PCB- and HCB-treated mice, but on the
Table 3. Graft-host activity ofspleen cells from C57BL/6 mice fed either a control diet, PCB 1016, or HCB for 3-37 weeks and
injected into neonatal BDF1 mice.a
Spleen indexa
Donor cell strain Diet 3 weeks 6 weeks 13 weeks 37 weeks
C57BL/6 Control 2.78 ± 0.21 2.07 ± 0.28 2.21 ± 0.12 2.24 ± 0.12
C57BL/6 PCB 2.77 ± 0.25 2.57 ± 0.34 2.13 ± 0.11 2.63 ± 0.20
C57BL/6 HCB 2.38 ± 0.28 2.26 ± 0.24 2.25 ± 0.12 1.80 ± 0.09*
BDF1 Control 1.10 ± 0.10 0.91 ± 0.02 0.93 ± 0.04
aData presented as mean spleen index ± standard error. See Material and Methods section for experimental details. There were
4-10 donor mice and 4-18 recipient mice for each diet group and each diet interval. Asterisk indicates statistical significance from
control value at p
- 0.01.
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mitogens (PHA and LPS responses): (e) control; (V) PCB; (O) HCB. See Materials and Methods section
forexperimental details. n = 4-6forall points. P (PCB) or H (HCB) indicates statistical significance from
control values at p G 0.05.
fourth day for spleen cells from control mice in the
6-week group, on the fourth day of culture in the
24-week group, and on the third day of culture in
the 40-week group. There were no significant
chemical-induced shifts ofthe time or magnitude of
the peak response.
Alloantigen-induced DNA synthesis in spleen
cells from C57BL/6 mice which were fed HCB for 3
weeks was significantly greater than control values
for days 1, 2, 3, and 5 of culture when stimulated
with DBA alloantigen. Although DNA synthesis in
mixed lymphocyte cultures ofC57BL/6 spleen cells
with DBA cells is significantly greater than the
control values on the first two days ofculture after
exposure to HCB 24 weeks and only on the firstday
ofculture after exposure to HCB for 40 weeks, the
increase is due to the elevated background synthe-
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sisobserved attheinitiationofcultures aspreviously
notedanddoesnotreflect analterationofalloantigen
reactivity.
Mitogen Responsiveness
Figure 4 also shows the mitogen-induced DNA
synthesis of cultured spleen cells from C57BL/6
mice which were fed a dietcontaining 167 ppm PCB
or HCB for 3-40 weeks. A transient increase in
tritiatedthymidine ([3H] - TdR) incorporation which
followed the addition of 40 ,ug/ml PHA-M (a T cell
mitogen) at the initiation of culture and which
generally peaked on day 2, but peaked on day 3 in
control and PCB-treated cultures in the 13-week
group, wasobserved inallcontroland experimental
Environmental Health Perspectives
1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6cultures. There were no significant changes from
control values in the time or amplitude ofthe peak
response as determined by (3H)-TdR incorporation
in cultures ofsplenocytes from mice which were fed
PCB for 3, 6, 13, or 40 weeks. However, following
24 weeks ofdietary exposure to PCB, a significant
increase in DNA synthesis was observed in PHA-
stimulated splenocytes on days 1, 3, and 6 of
cultures and was above control values, but not
statistically significant, on days 2, 4, and 5 of
culture. There were no significant shifts in the time
or magnitude ofthe peak response ofPHA-induced
DNA synthesis in splenocytes from mice which
werefed HCB althoughtheresponsewassignificantly
greaterthan control values on day 1 ofculture after
3 weeks exposure to HCB, significantly above
control values on days 1 and 3 of culture in the
24-week group and above control values on the first
day ofculture in the 40-week group. There were no
alterations in the 6- and 13-week groups. The
increase in DNA synthesis onday 1 ofculture inthe
24-week group and on day 1 in the 40-week group
are associated with the high background (3H)-TdR
incorporation rate previously mentioned and, there-
fore, do not represent chemical-induced alterations
of the response to PHA.
The addition of10 ,g/ml LPS (aB cellmitogen) at
the initiation ofcultures ofspleen cells from control
mice or mice fed either PCB or HCB for3-40 weeks
resulted in an increase in the (3H)-TdR incorpora-
tion rate, which generally peaked on days 2 or 3, in
all control and experimental cultures and the peak
responses in experimental cultures were compara-
ble to control values. However, LPS-induced DNA
synthesis was significantly greater than control
values on the sixth day of culture of splenocytes
from mice which were fed PCB for 3 weeks but
therewere nochemical-induced alterations observed
in mice which were fed PCB for 6, 13, or 24 weeks.
However, exposure'to PCB for 40 weeks resulted
in a profound decrease in LPS-induced DNA syn-
thesis on day 4 of culture.
LPS-induced DNA synthesis by spleen cells from
mice which were fed HCB for 3 weeks was above
control values on days 1 and 5 of culture but there
were no alterations observed in mice which were
fed HCB for 6 or 13 weeks. An increase in DNA
synthesis was observed onthe firstday ofculture of
cells from mice which were fed HCB for 24 weeks,
however, the increase is associated with the ele-
vated background (3H)-TdR incorporation rate
previously mentioned and, therefore, does not
represent chemical-induced alteration of the re-
sponse to LPS. However, exposure to HCB for 40
weeks resulted in a significant decrease in LPS-
induced DNA synthesis on days 4 and 5 ofculture.
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Cell-Mediated Lymphocytotoxicity (CML)
Sensitized spleen cells from C57BL/6 (H-2b) mice
fed a control diet for 3-40 weeks and immunized
with 2 x 107 live P815 (H-2d) tumor cells 10 days
prior to CML assays exhibited specific lysis of
1Cr-labeled cells which expressed the H-2d
alloantigen, i.e., P388 tumor (H-2d) (Fig. 5). There
was no lysis of allogeneic AKR (H-2k) PHA-blast
cells against which theywere notimmunized, which
indicated that lysis was specific, and there was no
lysis of syngeneic EL-4 (H-2b) tumor cells which
indicatedtheabsenceofanyalterationofcytotoxicity
directed against self. Only data for the lysis of the
P388 tumor are presented here; see Silkworth (102)
for complete data. Also, specific lysis of labeled
target cells by nonsensitized effector cells was less
than 5% in all trials.
The mean spontaneous release of label over the
5-hr incubation period for all intervals was 13% for
the P388 tumor, 10% for the EL-4 tumor, and 44%
forthe AKR PHA-blast cell. Maximum freeze-thaw
release of label was 83-88% for all labeled cells.
When the effector cells were from immunized
mice which were fed a control diet for 3, 6, and 13
weeks (Fig. 5), an effector cell:target cell ratio of
100:1 resulted in the progressive specific release of
51CrfromlabeledP388tumorcells ofapproximately
43% and 69% after 3 and 5 hr incubation, respec-
tively. However, effector cells from immunized
mice which were fed a control diet for 24 and 40
weeks caused the progressive specific 51Cr release
from P388 tumor cells of approximately 26% and
57% after 3 and 5 hrincubation, respectively, in the
24-week group and 16% and 36% after 3 and 5 hr
incubation, respectively, in the 40-week group.
These results may indicate an age-related decrease
in specific cytotoxicity in the control population
which began after 13 weeks of experimental hous-
ingand approximately 18weeks ofage. In addition,
an effector cell dose-response was observed when
effector cell:P388 target cell ratios of30:1 and 10:1
were used.
There were no significant alterations from con-
trolvalues ofthe specific lysis oflabeled target cells
by spleen cells from immunized C57BL/6 mice
which were fed 167ppm PCB 1016 for3 to 40weeks
(Fig. 5). There were no significant alterations from
control values ofthe specific lysis oflabeled target
cells by spleen cells of immunized C57BL/6 mice
which were fed 167 ppm HCB for 3, 13, 24, or 40
weeks (Fig. 5). However, the incubation of sensi-
tized spleen cells from mice exposed to HCB for 6
weeks with labeled P388 target cells at an effector:
target cellratio of100:1 resulted inthe significantly
decreased specific lysis of only 9% and 17% (20%
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,and 17% of the control value) after 3 and 5 hr
incubation, respectively. Similarly, effector:target
cell ratios of 30:1 resulted in the significantly
decreased specific lysis of4% and 7% (18% and 15%
of the control) after 3 and 5 hr incubation, respec-
tively, and at ratios of 10:1, a significantly de-
creased specific lysis of 1% and 2% (11% and 10% of
the control values) after 3 and 5 hr, respectively.
The ED50, that is, the number ofcells required to
cause 50% lysis as determined by linear regression
analysis of the dose-response values for each treat-
ment group of the 6-week exposure period, was
calculated for 3 and 5 hr incubation. The control
ED50 values were 2.25 x 106 and 1.4 x 106 for 3 and
5 hr, respectively. The ED50 values for the PCB-
treated group were 2.13 x 106 and 0.92 x 106 for 3
and 5 hr, respectively. The ED50 values for the
HCB-treated group were 11.39 x 106 and 6.01 x
106for3 and 5 hr, respectively, and represent 5-fold
and 6-fold decreases from control values after 3 and
5 hr incubation in effector cell ability to cause the
specific lysis of the target cells. In addition, there
was no alteration from the control response when
labeled EL-4 tumor cells were the target cells.
Residue Analysis
Electron capture liquid-gas chromatography of
serum, tissue and isolated spleen cells revealed that
PCB concentrations did not follow the same pattern
of disposition in all samples (Table 4). The concen-
tration of PCB in the liver decreased from the
3-week value during the 3-13 week period, after
which it increased to a steady state level. The
concentration of PCB in the spleen consistently
decreased from the 6-week value. The concentra-
tion of PCB in the thymus remained within 16% of
the median value during 40 weeks of exposure. The
concentration of PCB in the serum, although vary-
ing significantly from each previous measurement,
remained within 26% ofthe median value through-
out the observation period. And the concentration
of PCB in spleen cells remained within 22% of the
median value throughout the observation period.
HCB concentrations reached maximal levels in
liver during the 13 to 24 weeks exposure period.
The concentration ofHCB in the spleen reached its
highest level by 6 weeks, after which it decreased.
The HCB concentration in serum and thymus
reached its highest value by 24 weeks of exposure.
The concentration ofHCB in the spleen had reached
its highest level by 6 weeks, after which it de-
creased. The concentration of HCB in spleen cells
increased from 3 to 24 weeks, after which it
decreased, and the kinetics did not correlate with
those of whole spleen concentrations.
The ranges of the ratios of the concentrations of
HCB to PCB within the same exposure periods
were: liver, 4-11:1; spleen, 4-9:1; thymus, 1-4:1;
serum, 20-56:1; and spleen cells, 1:5-15. Neither
PCB nor HCB was found in random samples of
tissue from mice which were fed a control diet for
up to 40 weeks.
Discussion
The influence of the chronic dietary administra-
tion of two common environmental contaminants
(PCB and HCB) on several parameters of lympho-
cyte function has been investigated. PCB, at the
concentration used in this study, did not alter, in
any consistent manner, the graft-versus-host re-
sponse, themixedlymphocyte response, themitogenic
Table 4. PCB and HCB residue analysis.
Mean PCB or HCB concentration, ppma
Diet Tissue 3 weeks 6 weeks 13 weeks 24 weeks 40 weeks
PCB
Liver 13 ± 1.1 9.1 ± 2.3 4.6 ± 0.5 19 ± 2.9* 21 ± 6.3
Spleen 12 ± 0.2 6.2 + 0.9* 4.0 ± 0.8 3.4
Thymus 20 ± 2.9 19 ± 2.0 19- 19- 25 ± 5.2
Serum 0.18 ± 0.01 0.14 ± 0.01* 0.23 ± 0.02* 0.14 ± 0.01* 0.22 ± 0.01*
Spleen cells (ng/106 cells) 80 ± 23 95 ± 18 92 ± 10 61 ± 8.0
HCB
Liver 56 ± 5.6 49 ± 11 187 ± 12* 203 ± 42 115 ± 17
Spleen 59 ± 17 40 ± 1.3 18 ± 3.3* 31 ± 7.1
Thymus 18 ± 1.7 28 ± 6.0 47 9.6 70 ± 17 58 ± 11
Serum 3.5 ± 0.2 4.1 ± 0.4 7.9 ± 1.0* 8.0 ± 0.8 4.5 ± 0.6*
Spleen cells (ng/106 cells) 5.4 ± 1.5 6.3 ± 1.4 15 ± 2.4* 27 ± 2.6* 12 ± 3.3*
aData presented as mean concentration of PCB or HCB wet weight ± standard error; See Materials and Methods section for
experimental details; n= 1-5. Asterisk indicates statistical significance from previous sampling interval at p S 0.05 by analysis of
variance and Student's t-test.
June 1981 121response, or cytotoxic activity of spleen cells iso-
lated from experimental animals.
The time and the magnitude ofthe peakresponse
of spleen cells from PCB-treated mice in all mixed
lymphocyte and mitogen stimulated cultures were
comparable to the response of spleen cells from
control animals. These results indicate that PCB
did not consistently alter the initial recognition ofa
alloantigen or lymphocyte activation by mitogens,
as measured by DNA synthesis during the activa-
tion phase of the response. However, transient
alterations in PCB-treated lymphocyte function
were observed and deserve attention.
The increase in PHA-induced DNA synthesis
above control values observed following 24 weeks
of dietary exposure to PCB may be the result of
either an increase in the number of responsive T
cells and/or a PCB-induced impairment ofsuppres-
sor T cell function, which would permit a greater
than normal response. However, both the magni-
tude and the time of the peak response are com-
parable to control values. The 37% decrease in
LPS-induced spleen cell DNA synthesis which was
observed after 40 weeks dietary exposure in the
absenceofsimultaneousimpairmentofPHA-induced
DNA synthesis adds to the findings of Loose et al.
(80), who reported a 69% decrease in the number of
plaque-forming cells per million spleen cells during
the primary antibody response to SRBC inmice fed
PCB 1242 for6weeks. However, since the antibody
response to SRBC requires B lymphocytes, T
lymphocytes and macrophages (18), the cell type
which was the target cellforPCB toxicity, ifindeed
there was only one, could not be defined. Since LPS
is known to directly stimulate DNA synthesis in
cultures of B lymphocytes depleted of T lympho-
cytes and macrophages (103), PCB-induced impair-
ment of B lymphocyte activation is probably not
directly due to eitherimpaired Tlymphocyte helper
activity or macrophage function. These results
implicate the B cell as a possible target cell in
PCB-induced humoral immunotoxicity.
In the present study, the impairment of B
lymphocyte responsiveness to mitogen, however,
was not observed until after 40 weeks of PCB
exposure, whereas Loose et al. (80) demonstrated a
decrease in the number of plaque-forming cells
after 6 weeks ofPCB exposure. While the temporal
differences in these observations may be due to
differences in the experimental animal strains used
and/or the differences in the isomer contents ofthe
PCBsused, it is alsopossible that the plaque assay,
which detects the presence of plasma cells derived
from B lymphocytes responsive to sheep erythro-
cyte antigens, is more sensitive and, therefore,
better able to detect alterations from control re-
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sponses than the LPS mitogen assay, which detects
polyclonal B lymphocyte activation, due to the
inherent individual variation ofthe response ofthe
larger proportion ofresponding cells in the culture.
Although transient PCB-induced alterations ofB
lymphocyte mitogen responsiveness were observed
in the present study, there were no alterations of
cytotoxic activity against cell surface alloantigenby
sensitized lymphocytes from PCB-treated mice and
there was no increase in nonspecific killing. These
results suggest that PCB did not interfere with the
effector phase of the cell-mediated immune re-
sponse.
There were no alterations from control values of
body weight or relative spleen, thymus, or lung
weights or in the number of spleen cells isolated
from PCB-treated mice throughout the entire ex-
periment. Therelative liverweightwas significantly
greaterthan control values duringthe first 6 weeks
ofPCB exposure and is consistent with the findings
of other investigators (91) and is due to marked
proliferation ofsmooth endoplasmic reticulum (SER).
The findings of the present study extend the
previous evidence that PCBs alter humoral immu-
nity reported by Vos and Van Genderen (74),
Koller and Thigpen (75), and Loose et al. (80) and
suggest that PCBs can express selective toxicity on
different portions ofthe immune system. They also
indicate that the target site for PCBs causing the
depression of antibody-mediated immunity is a
mechanism and/or acelltype which is not shared by
the components of cell-mediated immunity. Since
Vos and Van Driel-Grootenhuis (91) reported that
exposure of guinea pigs to PCB resulted in a
decrease in the relative thymus weight and a
decreased delayed-type hypersensitivity skin reac-
tion, the present findings may also indicate species
differences in the susceptibility to PCB-induced
immunotoxicity. It is possible that a regulatory cell
which normally acts to balance both the cell-
mediated and the humoral-mediated arms of the
immune system is functionally impaired by PCBs
and allows an imbalanced response to occur.
Unlike PCB exposure, HCB exposure resulted in
the functional alteration oftwo ofthe parameters of
immune responsiveness measured in this study,
i.e., graft-versus-host activity and cell-mediated
lymphocytotoxicity. A 20% reduction ofGVH activ-
ity was observed after 37 weeks dietary exposure
to HCB. This result may indicate that splenomeg-
aly is not sensitive enough to detect a functional
alteration of GVH activity even though other
aspects of immune responsiveness are modified.
For example, Vos and Moore (104) reported that
four weekly doses of 25 ,ug/kg TCDD reduced the
GVH activity ofspleen cells ofyoung mice by 25%,
Environmental Health Perspectiveswhereas the responsiveness to PHA was reduced
67%. However, it may also indicate that the cells
involved in the graft rejection response are resis-
tant to acute chemical-induced functional alteration
and that only chronic chemical exposure results in
detectable immunotoxicity.
Chemical-induced alteration of immune function
may not always result in an impaired lymphoid
activity. Instead, enhanced activity of certain as-
pects ofimmune reactivity may occur and result in
an improper or unbalanced overall response.
A 32-76% increase in alloantigen-induced DNA
synthesis was observed in cultures of spleen cells
from mice fed HCB for 3 weeks. These results may
suggest that a population ofnonspecifically primed
lymphocytes was present in the cultures of HCB-
treated spleen cells and were able to support a
greater response to alloantigen than control cul-
tures during three days of the culture period,
however, the magnitude and time of the peak
response are not significantly different from the
control response. Since the kinetics ofthe response
were the same as the control response, it is
apparent that the increase in the rate of DNA
synthesis during the culture period was due to a
stimulus present in the culture, i.e., the allogeneic
stimulator cells, and not due to a preexisting
stimulus in vivo. This does not seem to be the case
with the increase in the background rate of DNA
synthesis observed following longer periods of
exposure to HCB and which will be discussed later.
There were no HCB-related alterations in alloan-
tigen-induced DNA synthesis, however, during the
40 week exposure period which followed.
Vos et al. (87) reported that HCB did not alter
skin rejection times of rats exposed to HCB pre-
and postnatally until 5 weeks of age. However,
allograft rejection also involves effector cell func-
tion and, therefore, evaluates the effector phase, in
addition to the recognition and activation phases of
the immune response.
A 51% increase in PHA-induced DNA synthesis
was observed following 24 weeks exposure to HCB
only on day 3 of culture. These results compare
with the findings ofVos et al. (87) that HCB did not
profoundly alter PHA responsiveness of spleen
cells from rats following pre- and postnatal dietary
exposure to 100 ppm HCB through 5 weeks of age
although a slight enhancement ofthe response was
noted. In addition, chemical-induced enhancement
ofthe lymphocyte response to a T cell mitogen may
represent an alteration in splenic T/B ratios and
lead to an inappropriate response to an antigen.
For example, if suppressor T cell function is in-
creased, due to the presence of an excessive num-
ber of T lymphocyte precursors, B lymphocyte
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differentiation into a sufficient number of antibody
producing plasma cells may also be impaired. Fur-
thermore, the present study extends the findings of
Vos et al. (87) by indicating that chronic exposure
ofexperimental animals to toxic compounds may be
necessary to detect certain immunological dysfunc-
tions.
A decrease of 50-53% in LPS-induced DNA
synthesis was observed after 40 weeks exposure to
HCB. However, no alterations from the control
response were observed in either the magnitude or
the time ofthe peakresponse. These results extend
the findings of Loose et al. (80) that the number of
PFCs per 106 spleen cells was decreased 53% below
control values after 6 weeks exposure to HCB and
since plaque forming cells are ofthe B cell lineage,
chemical-induced B lymphocyte dysfunction may be
indicated. In the same study, Loose also reported a
24% to 42% decrease in IgG1, IgA, and IgM in mice
fed HCB. These results provide more evidence that
there is a disparity inthe sensitivity between T and
B lymphocytes to HCB and that humoral immune
functions may be more sensitive than cell-mediated
immune parameters to the toxicity of HCB.
A 75-79% reduction in the specific cytotoxicity
directed against cell surface alloantigen by sensi-
tized spleen cells from mice exposed to HCB for 6
weeks is associated with the time when the highest
concentration of HCB was detected in the spleen.
Impairment oflymphocytotoxicity in the absence of
alteration of the recognition and activation phases
of the immune response indicates HCB-induced
functional alteration of the effector phase. This
hypothesis is supported by the decreased GVH
activity demonstrated in HCB-treated mice since
there is evidence which indicates that the effector
cells involved in GVH activity are the same
subpopulation of cells as those which are responsi-
ble for CTL (15). It is possible, however, and
difficult to exclude with certainty, that HCB-
induced alteration of host resistance (87, 105) to
infectious agents, such as bacteria, viruses and
protozoa, may result in a delayed response or even
dysfunction ofthe mechanisms ofhost defense and,
in turn, may have interfered with the cytotoxicity
assay. In addition, a 97% increase above control
values in the number of spleen cells isolated was
also observed. The high concentration of HCB in
the spleen may have caused impaired differentia-
tion ofprecursor cytolytic cells into effector cells or
thecompoundmayhaveinterferedwiththecytolytic
mechanism itself.
The 1431% increase in background DNA synthe-
sis observed during the first 24 hr of culture of
spleen cells from mice treated with HCB for 24
weeks was consistent with apattern whichbegan to
123develop after 6 weeks of HCB exposure. The
increased rate of DNA synthesis was no longer
present after 2 days of culture and suggests that
the population of cells which were synthesizing
DNA may have completed synthesis and entered
the mitotic and differentiation phases (although the
synchrony seems too great), may no longer be
viable in the culture, or, most probably, have lost
the stimulant for the initiation of DNA synthesis.
There are two possible explanations of enhanced
DNA synthesis. First, pathogenic organisms pres-
ent in the HCB-treated animals, due to a decreased
host resistance, but not present in control or
PCB-treated animals, would result in a chronic
condition of lymphoid activation, but would have,
perhaps, been eliminated from the cell preparation
during the isolation procedure. The absence of
bacteria in the blood and spleens of the HCB-
treated animals suggests that DNA synthesis is not
due to bacterial infection. Furthermore, there was
no increase in the number of splenic PMNs, which
would have indicated bacterial infection. Viral in-
fection of the HCB-treated animals is a strong
possibility and is indicated by the increase in the
relative lung weight and altered pulmonary histol-
ogy. Second, the enhanced rate of DNA synthesis
may be due to a compound with mitogenic proper-
ties present in vivo which is the result of HCB
exposure. The compound could be HCB itself, a
metabolite ofHCB not present inmitogenic concen-
trations in vitro or an HCB-induced cellular prod-
uct which is mitogenic. An increase in unstimulated
3H-thymidine uptake has alsobeen demonstrated in
spleen cell cultures from mice exposed to TCDD or
vinyl chloride (83, 84).
The body weights of mice fed HCB for 13 to 40
weeks were consistently less than control mice. A
decrease in the amount of adipose tissue was
apparent on gross examination and suggested an
alteration in lipid metabolism or food consumption,
but could not be attributed to a decrease in food
consumption due to the technical imprecision ofthe
feed weigh-back method available. A decrease in
the body weight and food consumption by rats fed
1000 mg/kg HCB for 3 weeks was reported by Vos
et al. (87). An increase in relative spleen weights of
mice fed HCB for 24 to 40 weeks could suggest
either immune reactivity since the percentage of
large lymphocytes present in the spleen cell sus-
pensions from mice treated with HCB for 40 weeks
was increased (although the increase was not great
enough to be statistically significant) or an increase
in hemopoiesis, since erythrocytes were more abun-
dant in the spleen cell preparations from HCB-
treated mice than from control mice. A decrease in
the relative thymus weights observed after 6, 13,
and 24 weeks ofexposure to HCB maybe associated
with the thymo-toxic properties seen with other
chlorinated hydrocarbons such as TCDD (104). In
addition, slight cortical atrophy ofthe thymus was
reported by Vos (87) in rats fed 2000 mg/kg HCB.
However, no histological alterations ofthe thymus
were observed in this study.
An increase in the relative liver weight observed
throughout the study is typical ofmany chlorinated
hydrocarbons such as PCB and reflects marked
proliferation of SER. It is difficult to delineate the
physiological response from hepatotoxicity (106),
however, and it is possible that alterations of
hepatic function may be directly or indirectly
associated with altered lymphoid function.
The greatest tissue concentrations of PCB were
in thymus and liver and indicates that the thymus,
aprimary lymphoid organ, may concentrate PCB to
levels above serum levels and may act as a storage
depot for PCB. Since Vos and Moore (104) found
that TCDD had a greater influence on CMI follow-
ing pre- and postnatal exposure than following
adult exposure, in addition to the lack of CMI
alteration found in the present study in which adult
animals were used, these data may indicate that
certain compounds are toxic to CMI function only if
exposure occurs during the development of the
immune system.
The highest tissue level of HCB was localized in
the liver and did not increase significantly after 13
weeks of exposure. The highest concentration of
HCB in the spleen was observed following 6 weeks
of exposure and was coincident with the observed
decrease in lymphocytotoxicity of spleen cells sen-
sitized against alloantigen and with the time when
the relative spleen weight was the highest value
recorded. After 6 weeks, the spleen concentration
had declined to, and remained at, less than one-half
its highest value and suggests an alteration in the
biohandling of the compound. Both spleen and
thymus concentrated HCB to values above serum
levels and it is ofinterest to note that as the spleen
concentration of HCB decreased with prolonged
exposure, the concentration of thymic HCB in-
creased. Sincetherelativethymusweightdecreased
during the 3-24 week period of exposure, while the
concentration ofHCB in the thymus increased, it is
possible that thymic affinity for HCB increased
with continued exposure or that the compound has
great avidity for a certain component of thymic
tissue and as other components are mobilized
during thymic weight loss, the HCB is retained.
The concept ofthymic receptor sites for chlorinated
hydrocarbons, such as TCDD, which seems to be
Environmental Health Perspectives 124under genetic control, has been suggested by
Poland et al. (107) and maybe related tothe altered
CMI responses observed in this study.
The influence of the dietary administration of
HCB on cell-mediated immune functions, in con-
trast to those observed with PCB, could reflect the
different patterns ofabsorption ofthese chemicals.
In rats, Iatropoulos et al. (67) demonstrated that 48
hr after oral administration of a single dose of
either 14C-labeled dichlorobiphenyl (DCB), a chlo-
rinated biphenyl, or HCB, that DCB is transported
to the liver by the venous portal system. In
contrast, HCB is primarily absorbed by the lym-
phatic system. This pattern of absorption of HCB
results in the direct exposure of thoracic duct
lymphocytes to high concentrations of chemical
before any detoxification by the liver or dilution in
the blood is possible. Thoracic duct lymphocyte
adsorption or absorption of HCB may help to
explain the high concentration of HCB found in
lymphoid tissue and its toxicity.
Inthe present study, the transient dysfunction of
cell-mediated immunological parameters, associated
with thymus weight reduction and spleen weight
increase, may reflect a thymus-dependent toxic
expression. That is, the thymotropic properties of
HCB result in high concentrations of HCB in
mature thymus tissue where it exerts thymotoxic
effects. There is evidence which suggests that the
immature thymus may be more susceptible to
permanent damage than the mature organ (104).
Reduction in thymus weight may be due to a
reduction of thymocyte development and since
nonprimed T lymphocytes are short-lived cells
(108), splenic T lymphocytes may not be replaced
and, therefore, T lymphocyte-mediated splenocyte
function may be impaired.
In the assessment ofthe mechanism ofaction by
which HCB caused the suppression of effector
phase function in the development of a cell-
mediated response, the data of the present study
suggest that the lesion is not due to an impaired
ability to recognize specific cell surface antigens.
Also, the lesion is probably not due to impairment
ofthe mechanism of lymphocyte activation since T
lymphocytemitogenresponsiveness, whichisthought
toby-pass initialspecificrecognition is notimpaired.
Therefore, the HCB-induced lesion probably exists
beyond antigen recognition and activation and ex-
istswithintheeffectorphasesincelymphocytotoxicity
and GVH reactivity, which are both measures of
effector cell function, were impaired following ex-
posure to HCB in this study.
In summary, the influence oftwo environmental
polyhalogenated aromatic hydrocarbons, PCB and
HCB, on the development ofcell-mediated immune
responses has beeninvestigated, anditisconcluded
that HCB is a more potent immunomodulator than
PCB, neither PCB norHCB interactinadetectable
and deleterious mannerwith the mechanisms ofthe
initial antigen recognition or activation phases of a
cell-mediated immune response, and cellular im-
mune dysfunction is related to exposure time to the
chemical. Furthermore, it is suggested that: (1) the
mechanism ofaction ofthe cellular immunotoxicity
of HCB is within the effector phase ofthe immune
response; (2) PCB has amore profound influence on
parameters ofantibody-mediated immunitythan on
cell-mediated immunity; (3) environmental chemi-
cals can have specific mechanisms of toxicity and,
therefore, can influence antibody-mediated immu-
nity while it has no detectable effect on cell-
mediated immunity; (4) a single assay of immune
function may not be appropriate to detect chemical-
induced immune dysfunction, and (5) due to the
temporal characteristics of the immune response,
the functional status ofthe immune system cannot
be evaluated on only one day of the response but
must be evaluated during the entire response
period to detect alterations in the magnitude or the
time of the peak response.
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